Ximelagatran reduces stroke risk in atrial fibrillation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1387, 2003-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ximelagatran reduces risk of VTE

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Valsartan reduces risk of atrial fibrillation in heart failure

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

In patients with atrial fibrillation, warfarin therapy commenced prior to detection of left atrial thrombus (LAT) reduces the incidence of stroke

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction

By Macchia Alejandro  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 627-634

Springer Publishing Company

Access to resources Recommend Favorite